https://www.reuters.com/business/healthcare-pharmaceuticals/eu-delays-approval-novavaxs-revised-covid-vaccine-ft-2023-10-15/
0
0
European Union (EU) regulators have delayed a decision to give approval for Novavax's <a href="https://www.reuters.com/markets/companies/NVAX.O" target="_blank">(NVAX.O)</a> variant-tailored COVID-19 vaccine, the company said on Sunday.
Create an account
or login to join the discussion